Prilosec Lawsuit Lawyers


Skilled and Empathetic Attorneys Pursuing Legal Claims for Prilosec Side Effects

If you or a loved one have suffered serious side effects like kidney disease or failure after taking Prilosec (generic: omeprazole), Prilosec OTC (omeprazole magnesium), or other Proton Pump Inhibitors for acid reflux or heartburn, you might be entitled to financial compensation.  Our Prilosec side effect attorneys are reviewing claims and investigating injury claims of individuals who have taken Proton Pump Inhibitors for the treatment of stomach acid, gastroesophageal reflux disease (GERD), heartburn, duodenal stomach or peptic ulcers, antacid, stomach acid, Zollinger-Ellison syndrome, Barrett’s esophagus, and other related conditions.

Lawsuits filed against AstraZeneca, the manufacturer of Prilosec, and Proctor & Gamble, manufacturer of Prilosec OTC, allege the pharmaceutical manufacturer sold the drug without sufficient testing, failed to warn of known risks, marketed an unsafe drug, and misrepresented the effectiveness of Prilosec.  These lawsuits allege that Prilosec, Prilosec OTC, and several other medications within the class of drugs known as Proton Pump Inhibitors contribute to serious kidney disease and kidney failure.  Our Prilosec lawsuit settlement attorneys are currently analyzing legal claims on behalf of Prilosec injury victims who suffer any of the following:

  • Kidney or Renal Failure
  • Acute Interstitial Nephritis
  • Chronic Kidney Disease
  • Kidney Transplant
  • Dialysis Treatment
  • Acute Kidney Injury

Free Case Evaluation: If you or a loved one has experienced kidney disease or failure after taking Prilosec in prescription or OTC form, we invite you to contact us for a free case evaluation at 1 (844) 808-7529.

What Is Prilosec and Prilosec OTC?

Prilosec was the first medication in the class of Proton Pump Inhibitors (PPIs) approved by the FDA for sale in the U.S. in 1989.  The drug functions by shutting down pumps in the stomach lining that produce acid used to break down food.  When the lower esophageal sphincter (LSC) relaxes, excess acid can travel up into the esophagus (reflux), which accounts for the pain associated with heartburn.  PPIs fight heartburn, GERD, and other gastroesophageal issues differently than drugs like antacids or histamine blockers.

FDA Warnings and Regulatory Actions

The FDA required the manufacturer of Prilosec to modify its labeling in 2014.  The federal agency mandated the product carry a warning regarding the risk of interstitial nephritis, which is characterized by inflammation of the kidney tubules.  When acute interstitial nephritis is not treated properly, the condition can evolve into chronic kidney disease and even kidney failure.  Although the drug has not been recalled by the FDA, studies since the FDA mandated labeling change has suggested a link between more serious kidney problems and the use of PPIs like Prilosec.

Scientific Research Linking Prilosec to Kidney Disease

Studies conducted before and after the FDA labeling change have indicated a link between Prilosec and several types of kidney disorders.  Research conducted since the FDA required warning suggests prolonged use of Prilosec in both prescription and over-the-counter forms causes kidney problems that can pose a more serious and immediate threat to patient health.

A study published in the Journal of the American Society of Nephrology found that long-term use of PPIs like Prilosec and Prilosec OTC exhibit a 96 percent increased risk of experiencing kidney failure and a 28 percent increased risk of chronic renal disease when compared to individuals taking other classes of heartburn medications.  These results were reinforced by a study published in JAMA Internal Medicine that revealed taking Prilosec and other PPIs might increase the risk of chronic kidney disease by as much as 50 percent.  Canadian researchers found that patients 75 and older who take PPIs like Prilosec also face an increased risk of acute kidney disease.

Prilosec Manufacturer Pays $7.9 Million Fine for Kickbacks & Other Violations

AstraZenica, the maker of Prilosec, was forced to pay a fine of $7.9 million in 2015 to resolve kickback allegations involving its other PPI drug Nexium.  The pharmaceutical company allegedly agreed to pay Medco Health Solutions for granting the drug exclusive status on certain lists of drugs that could be prescribed to patients.  The drug manufacturer allegedly used price concessions involving other medications, such as Prilosec to compensate Medco.

Free Case Evaluation for Prilosec Victims of Kidney Disease and Renal Failure

At Stern Law, PLLC, we are currently investigating claims for compensation on behalf of patients who have suffered severe side effects associated with Prilosec and other PPIs.  We invite you to give us a call today to see if you or a loved one is entitled to compensation for the harm you have suffered.  Patients who have experienced serious kidney disease or renal failure after extended use of Prilosec might have a right to compensation from the manufacturer of the drug for negligence and failure to warn consumers of the risk of serious adverse side effects.  Call Stern Law, PLLC today at 1 (844) 808-7529, or complete an online contact form for assistance.  Click here now for more information on scheduling your free case evaluation with one of our knowledgeable Prilosec disorder attorneys.




1 (844) 808-7529

Contact us 24/7. Call or click now! (844) 808-7529
Request a Call Back Start Your Case